The Exploration of Changes of CD4~+CD25~+ Regulatory T Cells in Peripheral Blood of Patients with Non-Hodgkin's Lymphoma
Kang Liu
Abstract
Kang Liu
Abstract
Objective: To detect the proportion of CD4+CD25+ regulatory T cells(Treg) in peripheral blood of patients with non-Hodgkin's lymphoma(NHL),and to explore the relationship between Treg and NHL.Methods: By using flow cytometry with surface staining fluorochrome-conjugated antibodies for CD4,CD25,the percentages of CD4+CD25+Treg in peripheral blood of 60 patients with NHL and 60 Healthy controls were detected and analyzed.Results: ①The average peripheral blood CD4+ levels of patients with NHL before chemotherapy was significant lower than that of the control group(P0.05),while the percentages of CD4+CD25+Treg was significant higher than that of the control group(P0.05).②After chemotherapy,the percentages of CD4+CD25+Treg was decreased and CD4+ levels was increased than before chemotherapy.The difference between them was statistically significant(P0.05).③ There was no significant difference between the control group and patients with NHL after chemotherapy of peripheral blood CD4+ level(P 0.05).But the percentages of CD4+CD25+Treg of patients with NHL after chemotherapy was still higher than the control group(P0.05).Conclusion: The increase in Tregs in patients with NHL may induce immune suppression and chemotherapy may cause the decreasing of Tregs.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To detect the proportion of CD4+CD25+ regulatory T cells(Treg) in peripheral blood of patients with non-Hodgkin's lymphoma(NHL),and to explore the relationship between Treg and NHL.Methods: By using flow cytometry with surface staining fluorochrome-conjugated antibodies for CD4,CD25,the percentages of CD4+CD25+Treg in peripheral blood of 60 patients with NHL and 60 Healthy controls were detected and analyzed.Results: ①The average peripheral blood CD4+ levels of patients with NHL before chemotherapy was significant lower than that of the control group(P0.05),while the percentages of CD4+CD25+Treg was significant higher than that of the control group(P0.05).②After chemotherapy,the percentages of CD4+CD25+Treg was decreased and CD4+ levels was increased than before chemotherapy.The difference between them was statistically significant(P0.05).③ There was no significant difference between the control group and patients with NHL after chemotherapy of peripheral blood CD4+ level(P 0.05).But the percentages of CD4+CD25+Treg of patients with NHL after chemotherapy was still higher than the control group(P0.05).Conclusion: The increase in Tregs in patients with NHL may induce immune suppression and chemotherapy may cause the decreasing of Tregs.
Key concepts: IL-2 receptor, Medicine, Lymphoma, Chemotherapy, Peripheral blood, Flow cytometry, Immune system, Non-Hodgkin's lymphoma